EF Hutton Initiates Coverage On Bionano Genomics with Buy Rating, Announces Price Target of $1.75
Portfolio Pulse from richadhand@benzinga.com
EF Hutton initiates coverage on Bionano Genomics (NASDAQ:BNGO) with a Buy rating and announces a price target of $1.75.
May 25, 2023 | 11:09 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
EF Hutton initiates coverage on Bionano Genomics with a Buy rating and a price target of $1.75.
The Buy rating and price target of $1.75 announced by EF Hutton for Bionano Genomics (BNGO) indicate a positive outlook for the stock. This news is likely to attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100